资讯

AviadoBio has launched its phase 1/2 Aspire-FTD trial in the UK, assessing AVB-101, a gene therapy targeting frontotemporal ...
A new clinical trial, delivered in Cardiff, will investigate the use of a one-time gene therapy to stop the disease ...